- CMMB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Chemomab Therapeutics (CMMB) S-3Shelf registration
Filed: 15 Apr 21, 4:03pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Chemomab Ltd.:
We consent to the use of our report dated March 16, 2021, with respect to the balance sheets of Chemomab Ltd. as of December 31, 2020 and 2019, the related statements of operations, changes in equity, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes, included herein and to the reference to our firm under the heading 'Experts' in the prospectus.
/s/ Somekh chaikin | |
Somekh Chaikin | |
Certified Public Accountants (lsr.) | |
Member Firm of KPMG International |
Tel Aviv, Israel
April 15, 2021
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.